Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeneTree (Beijing GeneTree Medical Technology) is a leading biotechnology company specializing in advanced molecular diagnostics and precision medicine. The company is a pioneer in the clinical application of metagenomic next-generation sequencing (mNGS) for the rapid and comprehensive identification of pathogens in complex clinical samples, addressing critical needs in infectious disease management such as sepsis and severe pneumonia. Beyond infectious diseases, GeneTree provides a robust portfolio of genomic testing services for oncology, including tumor mutational profiling and hereditary cancer screening. By integrating high-throughput sequencing technology with proprietary bioinformatics pipelines, the company enables clinicians to make data-driven decisions for personalized patient care. GeneTree operates several high-standard clinical laboratories and maintains a significant commercial presence across hospitals and research institutions in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GeneTree.